Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study.

Nickel MK, Nickel C, Muehlbacher M, Leiberich PK, Kaplan P, Lahmann C, Tritt K, Krawczyk J, Kettler C, Egger C, Rother WK, Loew TH.

J Clin Psychopharmacol. 2005 Jun;25(3):211-7.

PMID:
15876898
2.

Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.

Bays H.

Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1777-801. doi: 10.1586/erc.10.125. Epub 2010 Aug 16. Review.

PMID:
20707765
3.

A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Kiortsis DN.

Hormones (Athens). 2013 Oct-Dec;12(4):507-16. Review.

4.

Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials.

Kramer CK, Leitão CB, Pinto LC, Canani LH, Azevedo MJ, Gross JL.

Obes Rev. 2011 May;12(5):e338-47. doi: 10.1111/j.1467-789X.2010.00846.x. Epub 2011 Mar 28. Review.

PMID:
21438989
5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
6.

Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Ellinger LK, Ipema HJ, Stachnik JM.

Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16. Review.

PMID:
20233913
7.

Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents.

Mahmood S, Booker I, Huang J, Coleman CI.

J Clin Psychopharmacol. 2013 Feb;33(1):90-4. doi: 10.1097/JCP.0b013e31827cb2b7. Review.

PMID:
23277264
8.

Topiramate for the prophylaxis of episodic migraine in adults.

Linde M, Mulleners WM, Chronicle EP, McCrory DC.

Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010610. doi: 10.1002/14651858.CD010610. Review.

PMID:
23797676
9.

Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.

Kelly EM, Tungol AA, Wesolowicz LA.

J Manag Care Pharm. 2013 Oct;19(8):642-54. Review.

10.

Topiramate: a new potential pharmacological treatment for obesity.

Astrup A, Toubro S.

Obes Res. 2004 Dec;12 Suppl:167S-73S. Review.

11.

Topiramate monotherapy for weight reduction in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.

Paravattil B, Wilby KJ, Turgeon R.

Diabetes Res Clin Pract. 2016 Apr;114:9-14. doi: 10.1016/j.diabres.2016.02.002. Epub 2016 Feb 17. Review.

PMID:
27103363

Supplemental Content

Support Center